Carmell Therapeutics - XAGE Quick Liquidity

Longevity Health Holdings (XAGE) promotes advanced cellular skin renewal methods using Carmell systems, as evidenced by the price trend visualization where the liquidity ratio stands at 0.00. The brand's US-based capacities produce regenerative products based on patented bioactive components. However, structural mergers and competition within the premium cosmetics segment create operational pressure and require significant promotional investments, reducing free cash flow.

Longevity Health Holdings Inc (XAGE) - Immediate Liquidity from 03/11/2025 to 09/27/2025

carmellcosmetics.com - analytical breakdowns and key metrics (XAGE)

- share price and consensus valuation forecast:
Stock Quotes Longevity Health Holdings Inc|XAGE - Analyst Forecast Prices
- issuer market value details:
Market Value Longevity Health Holdings Inc|XAGE - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share Longevity Health Holdings|XAGE - Total Stockholders' Equity|Market Value to Book Value Ratio carmellcosmetics.com|XAGE - Total Business Assets
- debt and liquidity details:
Total Debt to Equity Ratio Longevity Health Holdings|XAGE - Long-Term Loans to Capital Ratio|Short-Term Debt to Equity Carmell Therapeutics|XAGE - Company Debts|Debt to Book Capitalization Ratio Longevity Health Holdings Inc|XAGE - Long-Term Debt|Company Short-Term Debt Longevity Health Holdings|Quick Ratio carmellcosmetics.com
- earnings and valuation multiples indicators:
XAGE - Annual Net Income
Fundamental valuation:Longevity Health Holdings

The analyst assesses the credit quality of Longevity Health Holdings (XAGE) through the company's ability to immediately settle its debts. Premium cosmetics sales via clinics and online channels ensure a steady inflow of liquid funds. The current quick ratio reflects the proportion of cash assets and accounts receivable relative to liabilities, excluding slow-moving serum inventories. While high values confirm solvency, an excessive metric may signal inefficient capital utilization.

Analysis of competing companies

HCA (hcahealthcare.com) - Quick Liquidity Indicator|THC: Intermediate Liquidity Ratio|Quick Liquidity Fresenius Medical Care|Quick Liquidity Indicator solventum.com (SOLV)|Quick Ratio EHC|UHS - Immediate Liquidity|Quick Liquidity DaVita Inc DVA|RDNT: Immediate Liquidity Ratio|OPCH: Quick Liquidity Indicator|surgerypartners.com - Intermediate Liquidity Ratio|Premier (PINC) - Quick Liquidity|EYE (National Vision Holdings, Inc.) - Quick Liquidity|Quick Liquidity Progyny Health|Immediate Liquidity Ardent Health Corp ARDT|Quick Liquidity Select Medical (SEM)|astranahealth.com - Immediate Liquidity Ratio|Quick Ratio MD (Pediatrix Medical Group, Inc.)|Critical Liquidity US Physical Therapy|Pennant Group Inc - Quick Ratio|Immediate Liquidity Organogenesis Corp|NUTX (Nutex Health Inc.) - Quick Liquidity Indicator|AUNA (aunainvestors.com) - Quick Liquidity|SBC (SBC Medical Group Holdings Inc.) - Quick Ratio|Evolus Inc (EOLS) - Interim Coverage Ratio|Quick Liquidity Indicator CYH (Community Health Systems Inc)|Intermediate Liquidity Ratio SKIN|MediWound - Quick Liquidity Indicator|biote.com (BTMD) - Immediate Liquidity|JYNT: Quick Liquidity Indicator|Intermediate Coverage Ratio DCGO (DocGo, Inc.)|PIII: Quick Ratio|Gain Therapeutics Inc. - Intermediate Coverage Ratio|EUDA (EUDA Health) - Quick Ratio|Immediate Liquidity Basel Medical Group Limited BMGL|Quick Ratio CLGN|Quick Ratio Cuprina Holdings (Cayman) Ltd. (CUPR)|Quick Liquidity Concord Medical Services Holdings Limited CCM|ASHS - Quick Liquidity|MRM: Quick Liquidity Indicator|Avalon GloboCare - Intermediate Liquidity Ratio|DHAI: Quick Ratio|NewGenIvf Group - Intermediate Coverage Ratio|Quick Liquidity Indicator ATIP|CMAX: Intermediate Coverage Ratio|Quick Ratio KDLY|MODV (modivcare.com) - Intermediate Coverage Ratio|Quick Liquidity Novo Integrated Sciences, Inc. NVOS|SunLink Health Systems Inc. (SSY) - Immediate Liquidity|BACK - Quick Liquidity